Technical Analysis for EIGR - Eiger BioPharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 8.515 0.29% 0.03
EIGR closed up 1.56 percent on Thursday, April 22, 2021, on 65 percent of normal volume.
Earnings due: May 5
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical EIGR trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.29%
Bollinger Band Squeeze Range Contraction 0.29%
Up 3 Days in a Row Strength 0.29%
Slingshot Bearish Bearish Swing Setup 1.85%
Bollinger Band Squeeze Range Contraction 1.85%
Bollinger Band Squeeze Range Contraction 4.10%
Stochastic Reached Oversold Weakness 4.10%
BB Squeeze + Lower Band Touch Range Contraction 4.10%
Lower Bollinger Band Touch Weakness 4.10%
Oversold Stochastic Weakness 4.10%
Older End-of-Day Signals for EIGR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
20 DMA Support 7 minutes ago
Rose Above 20 DMA 42 minutes ago
Rose Above Previous Day's High 42 minutes ago
Up 1% 42 minutes ago
Rose Above 20 DMA about 22 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Eiger BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops a portfolio of late-stage drugs for orphan diseases. It offers Sarasar, which is used for the treatment of hepatitis delta; Exendin that is used for the treatment of hypoglycemia; and Bestatin, which is used for the treatment of pulmonary arterial hypertension and lymphedema. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is based in Palo Alto, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Hypertension Specialty Drugs Pulmonary Arterial Hypertension Hepatitis Biopharmaceuticals Orphan Disease Orphan Diseases Pulmonary Hypertension Treatment Of Hepatitis Hypoglycemia Lymphedema

Is EIGR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.99
52 Week Low 6.76
Average Volume 201,711
200-Day Moving Average 10.02
50-Day Moving Average 9.59
20-Day Moving Average 8.53
10-Day Moving Average 8.33
Average True Range 0.46
ADX 36.86
+DI 16.08
-DI 25.40
Chandelier Exit (Long, 3 ATRs ) 8.10
Chandelier Exit (Short, 3 ATRs ) 9.23
Upper Bollinger Band 9.08
Lower Bollinger Band 7.97
Percent B (%b) 0.47
BandWidth 13.10
MACD Line -0.34
MACD Signal Line -0.39
MACD Histogram 0.0535
Fundamentals Value
Market Cap 276.19 Million
Num Shares 32.5 Million
EPS -3.65
Price-to-Earnings (P/E) Ratio -2.33
Price-to-Sales 0.00
Price-to-Book 3.22
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.05
Resistance 3 (R3) 9.02 8.80 8.95
Resistance 2 (R2) 8.80 8.66 8.82 8.92
Resistance 1 (R1) 8.65 8.57 8.73 8.68 8.89
Pivot Point 8.43 8.43 8.47 8.45 8.43
Support 1 (S1) 8.28 8.29 8.36 8.31 8.09
Support 2 (S2) 8.06 8.20 8.08 8.06
Support 3 (S3) 7.91 8.06 8.03
Support 4 (S4) 7.94